Human Biobanking Ownership - Global Trends, Estimates and Forecasts, 2014-2020 - Industry Overview

Human Biobanking Ownership - Global Trends, Estimates and Forecasts, 2014-2020 - Industry Overview

Biobanks are large collections of biological specimens (tissue and blood samples) with individual specimen information developed under the auspices of public or private initiative for use in biomedical research. Biobanks contain large collections of DNA collected from individuals diagnosed of specific diseases accompanied by detailed health history. Researchers and clinicians investigate biospecimens of specific individuals for indications/diagnosis of disease. These specimens could be used to get DNA, proteins and other molecules that may help in understanding disease progression.

Steps to compile preserve and supply samples for experimentation and study have led to the growth of a fresh dimension in biobanking. Though to organize larger facilities the steps are evident, but huge numbers of DNA, RNA and tissue samples that are present in freezers in personal labs all across the globe is much more than the numbers in the compilations preserved in the national and organizational bio facilities. Having mentioned it would be ridden with problems to use samples collected by different individuals at different locations.

Medical and Genealogical data related to the samples stored in a Biobank are equally important, and Biobanks can be termed as both scientific and social projects. The rapid advances made in genome science of late have made it considerably easier to obtain, save and analyze genetic data.

Thus, large Biobanks can now be analyzed in greater depth, helping to enhance understanding of the biodiversity of the human race. On a large scale, it is vital that Biobanks and related issues are standardized and established across the globe, especially in developing countries.

This is an ongoing process, and there is as yet no particular set of procedures that can be called ―best‖, but there is worldwide focus on improving in this area. The ultimate objective of any Biospecimen resource is to indentify Biomarkers (measurable indicators of disease in a given sample), and this analysis must be done without bias on specimens that have not been compromised in their quality or integrity.

Current advances in genomics technology have made it possible to obtain genetic information from these collections in a faster, cheaper and easier manner for whole genome analysis. Biobanks should be used for investigating the biological biodiversity seen among human populations.

The key to developing personalized medicine and achieving translational research success is ensuring that proven methods are used to extract, store and process high-quality Bio-samples. There has been, and will be, a lot of effort to standardize methods and techniques so that Biobanks across the world can be assured of quality practices.

However, the demands made of modern Biobanks are beginning to outpace the finances available, and so the biorepositories might have to be more selective in what they store and the methods they employ to preserve their samples.

Biobanking is getting recognition a May donor samples and medical data is preserved in bio banks gaining all over the world. The unique innovations are helpful to both the government and to research facilities to analyze and keep record of the bio-sample compilation.